ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974

Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin

July 27, 2012

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates

July 1, 2011